Addressing the risk and management of cardiometabolic complications in prostate cancer patients on androgen deprivation therapy and androgen receptor axis-targeted therapy: consensus statements from…

Overview of attention for article published in Frontiers in oncology, January 2024

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (75th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

twitter: 11 X users

Readers on

mendeley: 5 Mendeley

So far, Altmetric has seen 13 X posts from 11 X users, with an upper bound of 45,948 followers.

RT @DrDarrenPoon: @DrYukselUrun @JournalCancer @ASCO @APCCC_Lugano @OncoAlert @PCFnews @CancerDotNet @cancereu @CaPsurvivorship @yekeduz_em…

Reply Repost Favourite

@DrYukselUrun @JournalCancer @ASCO @APCCC_Lugano @OncoAlert @PCFnews @CancerDotNet @cancereu @CaPsurvivorship @yekeduz_emre @neerajaiims @DrChoueiri @Silke_Gillessen @dmukherji @AzadOncology @shilpaonc @Prof_IanD @AarmstrongDuke Now PCa pts lives longer, t

Reply Repost Favourite

RT @DrDarrenPoon: Delighted to publish our works @FrontOncology. ADT & AR-agents related cardiometabolic risk and its management in PCa pa…

Reply Repost Favourite

RT @DrDarrenPoon: Delighted to publish our works @FrontOncology. ADT & AR-agents related cardiometabolic risk and its management in PCa pa…

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.